Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
US-2024101580-A1 · Mar 28, 2024 · US
US12065456B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12065456-B2 |
| Application number | US-202016881272-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 22, 2020 |
| Priority date | Jul 25, 2019 |
| Publication date | Aug 20, 2024 |
| Grant date | Aug 20, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are boron-containing compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders.
Opening claim text (preview).
The invention claimed is: 1. A compound of Formula Ia: or a pharmaceutically acceptable salt thereof; wherein B is boron; and W is absent or C(R 3 ) 2 ; and R 3 is independently, at each occurrence, selected from the group consisting of H, halo, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 6 -C 10 aryl, C 5 -C 10 heteroaryl, C 3 -C 10 cycloalkyl, and C 3 -C 10 heterocycloalkyl. 2. The compound of claim 1 , wherein W is absent. 3. The compound of claim 1 , wherein W is CH 2 . 4. The compound of claim 1 , wherein W is C(R 3 ) 2 .
Boronic and borinic acid compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.